Search results
Showing 31 to 45 of 94 results for template
trublood-prostate for triaging and diagnosing people with prostate cancer symptoms (MIB268)
NICE has developed a medtech innovation briefing (MIB) on trublood-prostate for triaging and diagnosing people with prostate cancer symptoms .
This guideline covers good practice for developing, authorising, using and updating patient group directions. It also offers advice on deciding whether a patient group direction is needed.
View recommendations for MPG2Show all sections
NICE has developed a medtech innovation briefing (MIB) on Paige Prostate for prostate cancer .
evidence, the committee recommended not offering mapping transperineal template biopsy as an initial biopsy, because the technique is...
evidence, the committee recommended not offering mapping transperineal template biopsy as an initial biopsy, because the technique is...
evidence, the committee recommended not offering mapping transperineal template biopsy as an initial biopsy, because the technique is...
Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Transperineal template biopsy and mapping of the prostate (IPG364)
Interventional procedures, IPG364 - Issued: October 2010 --> We have moved interventional procedures guidance 364 to become HealthTech guidance 237. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This document is one of a series describing the processes and methods that NICE uses to carry out technology appraisals. It focuses on the technology appraisal processes
NICE has developed a Medtech Innovation Briefing (MIB) on the Oncentra Prostate v4.x ultrasound-guided real-time HDR brachytherapy in men with localised
technology appraisal submission to NICE Technology appraisal submission templates and supporting documents Technology appraisal data:...
Information and links to key resources that will help you keep your practice up-to-date.
NICE has developed a medtech innovation briefing (MIB) on Stockholm3 for prostate cancer screening .
This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services should be organised, including the role of the TB control board.
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies